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Background: Survival from cancer in older patients is poorer in the UK than other
countries with similar health systems and wealth possibly due to undertreatment and
increased toxicities in this specific population. This population-based observational
study describes factors affecting systemic anticancer treatment (SACT) use in older
patients in England.
Methods:We identified patients aged70 with stage II-III breast cancer, stage III colon
cancer and stage IIIB-IV non-small cell lung cancer (NSCLC) diagnosed in 2014 from a
dataset collected by the National Health Service in England.We used logistic regression
to estimate factors affecting likelihood of receiving SACT and performed separate
regression analyses for each disease, adjusting for age, gender, stage at diagnosis, patho-
logical features, performance status, Charlson comorbidity index, ethnicity and socioe-
conomic group.We assessed 2-year overall survival (OS) using Kaplan-Meier method.
Case mix adjusted treatment rates and workload volume were calculated at hospital
level and presented using funnel plots, stratified by age groups (<70 and70) to allow
for assessment of variation between centres.
Results: 36892 patients were identified: 19879 with stage II-III breast cancer, 5292 with
stage III colon cancer and 11721 with stage IIIB-IV NSCLC. Patients over 70 were less
likely to receive SACT compared to those aged under 70: breast 11.7% vs 64.6%,
p< 0.001; colon 37.4% vs 79%, p< 0.001; NSCLC 33.5% vs 60.2%, p< 0.001. 2-year
OS for patients receiving SACT was similar for patients aged70 and<70: breast
91.5% (95%CI: 89.3%-93.2%) vs 96.4% (95%CI: 95.9%-96.7%); colon 84.8% (95%
CI: 82.6%-86.8%) vs 88.3% (95%CI: 86.7%-89.8%); NSCLC 16.7% (95%CI: 15.1%-
18.4%) vs 19.8% (95%CI: 18.5%-21.1%). Patients receiving SACT had better OS than
those untreated. SACT rates varied widely between hospitals after adjusting for case-
mix across all ages.
Conclusions:Our study suggests that several factors affect the likelihood of receiving
SACT but after adjusting for these, age remains determinant. Identifying hospitals with
significantly lower SACT rates should prompt local review of multidisciplinary team
practice.
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Background: Breast cancer (BC) is the most common cancer among women. In Egypt,
BC accounts for 38% of all types of cancer in females with the majority often present at
advanced stages. This might be attributed to defective health education programs and
poor awareness. The aim of this study is to evaluate the knowledge, attitude and prac-
tice of Egyptian nurses at Tanta university hospitals towards BC.
Methods: 421 female nurses from Tanta university hospitals completed a questionnaire
that administred through face-to-face interviews by medical students and interns. The
questionnaire included five sections: sociodemographic data, knowledge about BC
symptoms, risk factors, screenings methods and treatment of BC.
Results:Mean knowledge score was 18.756 5.76 with 57.2% of participants knew the
right answers of more than 50% of the questions. The least level of knowledge was in
questions related to BC symptoms and risk factors with 60.3% and 52.2% , respectively,
of participants had scores of< 50% of the total score. The knowledge for nurses aged
30-39 years-old, those from urban areas and those who have years of work experience
ranged between 16 and 25 years had statistically lower levels of knowledge compared to
other groups (p value, 0.035, 0.048, 0.005, respectively).
Conclusions: The level of BC knowledge among Tanta university hospitals nursing staff
is fair. The Knowledge about BC symptoms and risk factors needs more attention from
health care authorities to specifically design educational programs focusing on these
areas.
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Background:Medical Oncology is a feminized profession in Spain. According to
SEOM, 57,6% of the medical oncologists in this country are women. This situation will
remain unchanged because women occupied 67% of the medical oncology training
positions since 2008. However, women are underrepresented in leadership possitions,
whichmay influence their career development.
Methods:We reviewed the participation, role and gender distribution of 2110 profes-
sionals at SEOM annual meetings between 2009-2017, the possition of the 237mem-
bers of SEOM executive boards (1976-2017) and the 355members of the current
executive boards of 13 of the most important Spanish cooperative groups.
Results: From 2009 to 2017 the 38,4% of the 2110 speakers at SEOMmeetings were
women. There wasnt a progressing increase over the years. The only year with>40% of
female participation was 2017 (42,4%). At educational and clinical sessions, 26% of
chairs and 35% of speakers were women. At original presentations sessions, 57% of pre-
senters, 42% of discusors and 30% of chairs were women. At the plenary sessions, 50%
of presenters, 17% of discusors and 5% of chairs were women. 31% of members of sci-
entific committees were women; they chaired these panels in 22% of cases. Over the last
decade, SEOM awarded 122 research grants, 42% of them to women. The SEOM execu-
tive board has been chaired 18 times by aman and 2 by a woman. The first female presi-
dent was elected in 2011. There were no women at executive boards until 1987.Women
occupied 17,3% of the possitions. Currently, 40% of the executive boards members and
2 of the 13 cooperative groups chairs are women.
Conclusions: Spanish women oncologists developed an active cientific activity in their
everyday practice and communicated their research data at national meetings.
However they were asked to chair or share their expertise in fewer occasions thanmen.
In addition, women were underrepresented at executive boards of the main oncology
scientific groups. According to our results, we consider further efforts are required to
achieve gender equality. A good example are initiatives like the ESMOWomen for
Oncology (W4O) network, the Forum ofWomen in Oncology in Greece orW4O Italy.
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Background: Each year, 355,000 new individuals are diagnosed with cancer in France,
nearly half of them being in working age and interrupting their professional occupation
during treatments. As having working arrangements has been found to facilitate return
to work after a long absence, it is provided by French law. This study aims to describe
the use of working arrangements and to investigate how it is related to job retention.
Methods: This study combines analyses of quantitative and qualitative data: 1)
VICAN5, a national representative survey on living conditions 5 years after cancer diag-
nosis conducted in 2015-2016 (n¼ 4,174), and 2) CAREMAJOB, a qualitative longitu-
dinal study carried out in 2017 among patients on sick leave after a cancer diagnosis
and interviewed about the impact of the disease on their working lives (n¼ 21).
VICAN5 survey presents an overview about the use of working arrangements in France
and the CAREMAJOB survey completes these results by giving the patients’ point of
view in amore comprehensive manner.
Results: Among the 1,854 cancer survivors aged between 23 and 59 at time of the
VICAN survey, and who were employed at diagnosis, 62.7% used working arrange-
ment(s) within the five years following diagnosis. Nearly half of them (45.5%) had a
working time arrangement. The other kind of working changes were about working
hours (38.8%), working conditions (35.8%), occupation (32.8%), workplace (20.4%),
and security at work (19.2%). Moreover, working arrangements are associated with job
retention (88.9% of workers with working arrangement were still employed five years
after diagnosis versus 69.6% of others). Furthermore, in CAREMAJOB survey, when
patient returned to work without any working arrangement, this led to bad experience
because of workload. However, some of those who did have an arrangement reported a
negative impact on their professional life: they felt discriminated or thought that it has
affected their professional credibility.
Annals of Oncology abstracts
Volume 29 | Supplement 8 | October 2018 doi:10.1093/annonc/mdy297 | viii567
